查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1631209

美国组织诊断市场规模、份额、趋势分析报告：按技术/产品、应用和细分市场预测，2025-2030 年

U.S. Tissue Diagnostics Market Size, Share & Trends Analysis Report By Technology & Product (IHC, Primary & Special Staining), By Application (Breast Cancer, NSCLC), And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

美国组织诊断市场的成长与趋势

根据 Grand View Research, Inc. 的一份新报告，美国组织诊断市场规模预计到 2030 年将达到 44 亿美元，2025 年至 2030 年期间的复合年增长率为 8.3%。促进市场成长的关键因素包括美国癌症患者数量的持续增加、器官移植和捐赠数量的增加、以及个人化医疗和伴同性诊断的接受度不断提高。

由于美国癌症发生率的急剧增长，解剖病理学领域正在经历模式转移。此外，分子病理学与解剖病理学的稳定融合、癌症检测新型切片检查的快速采用以及数位技术的整合预计将共同对市场成长产生积极影响。

组织分析描述了传统分子技术难以理解的重要资讯。目前，製药公司正在迅速采用伴同性诊断测试来为其产品获得第一线治疗指定/核准。此外，组织诊断在精准医疗的发展中变得越来越重要，因为它可用于识别可能受益于标靶治疗的患者群体。

此外，随着萤光原位杂合反应(FISH)、免疫组织化学 (IHC)、萤光(IF)、比较基因组杂合反应和次世代定序(NGS) 等升级技术的采用，组织诊断领域正在逐步发展。主要企业正致力于识别新型生物标记和开发先进的癌症诊断检测方法。此外，该公司正在实施生物标记病理学家培训计划，以增加对最新病理学解决方案的采用。

美国组织诊断市场报告重点

  • 基于技术和产品，免疫组织化学领域预计将在 2024 年以 27.74% 的最大收入份额引领市场。
  • 根据应用，乳癌领域将在 2024 年占据市场最大收入份额，达到 50.45%。组织诊断在评估乳癌患者中起着重要作用。
  • 按最终用途划分，医院部门占据市场主导地位，2024 年的收入份额最大，为 37.82%。医院和诊所对组织诊断系统和服务的使用正在逐年增加。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章美国组织诊断市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国组织诊断市场分析工具
    • 产业分析 – 波特五力分析
    • PESTEL 分析

美国4 章。

  • 细分仪表板
  • 美国组织诊断市场：技术与产品变化分析
  • 美国组织诊断市场：技术与产品展望
  • 2018-2030 年市场规模、预测及趋势分析
  • 免疫组织化学
    • 装置
    • 耗材
  • 原位杂合反应
    • 装置
    • 耗材
    • 软体
  • 原发染色及特殊染色
    • H&E 染色
    • 特殊染色
  • 数位病理学和工作流程
    • 全幻灯片成像
    • 影像分析资讯学
    • 资讯管理系统储存与通讯
  • 解剖病理学
    • 装置
    • 耗材

美国5 章。

  • 细分仪表板
  • 美国组织诊断市场：应用趋势分析
  • 美国组织诊断市场：应用展望
  • 2018-2030 年市场规模、预测及趋势分析
  • 乳癌
  • 非小细胞肺癌
  • 摄护腺癌
  • 胃癌
  • 其他癌症

美国章。

  • 细分仪表板
  • 美国组织诊断市场：最终用途差异分析
  • 美国组织诊断市场前景（按最终用途划分）
  • 2018-2030 年市场规模、预测及趋势分析
  • 医院
  • 实验室
  • 製药协会
  • 执行长

第七章 竞争格局

  • 市场参与企业分类
  • 主要市场参与企业的近期趋势及影响分析
  • 2024 年公司市场占有率分析
  • 主要企业简介
    • Merck KGaA
    • Thermo Fisher Scientific, Inc
    • F. Hoffmann-La Roche Ltd
    • Abbott Laboratories
    • Siemens Healthineers AG
    • Danaher
    • bioMerieux SA
    • QIAGEN
    • Becton, Dickinson &Company（BD）
    • Agilent Technologies, Inc
    • General Electric Company
    • BioGenex
    • Cell Signaling Technology, Inc
    • Bio SB
    • DiaGenic ASA
    • Sakura Finetek Japan Co., Ltd
    • Abcam plc
    • Enzo Life Sciences, Inc
    • VITRO SA（Master Diagnostica）
    • TissueGnostics GmbH
Product Code: GVR-4-68038-270-9

U.S. Tissue Diagnostics Market Growth & Trends:

The U.S. tissue diagnostics market size is estimated to reach USD 4.40 billion by 2030, registering a CAGR of 8.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. Pivotal factors supplementing the market growth include continuous rise in the cases of cancer, growth in organ transplantation & donation, and increased acceptance toward personalized medicine & companion diagnostics in the U.S. Increase in the number of research activities targeted toward the development of novel tissue diagnostics solutions is also expected to drive the market.

The field of anatomic pathology has witnessed a paradigm shift, which can be attributed to the exponential growth in cancer incidence in the U.S., thereby expanding the clinical pathology industry. Also, steady convergence of molecular pathology with anatomic pathology, steep adoption of novel biopsies for cancer detection, and integration of digital technologies is expected to collaboratively make a positive impact on market growth.

Tissue analysis provides significant information, which is difficult to understand using conventional molecular techniques. Currently, companion diagnostic tests are rapidly being adopted by pharmaceutical companies for obtaining first-line therapy designations/approvals for their products. In addition, their use in the identification of patient cohorts, which are likely to benefit from targeted therapeutics, has increased the significance of tissue diagnostics in the development of precision medicine.

In addition, the field of tissue diagnostics has witnessed gradual evolution with the introduction of upgraded technologies, including Fluorescence In Situ Hybridization (FISH), Immunohistochemistry (IHC), Immunofluorescence (IF), comparative genomic hybridization, and Next-Generation Sequencing (NGS). Key players are focused on identifying novel biomarkers and developing assays for advanced cancer diagnosis. Furthermore, companies are conducting biomarker pathologist training programs to boost the adoption rate of modern pathological solutions.

U.S. Tissue Diagnostics Market Report Highlights:

  • Based on technology & product, the immunohistochemistry segment led the market with the largest revenue share of 27.74% in 2024.
  • Based on application, the breast cancer segment led the market with the largest revenue share of 50.45% in 2024. Tissue diagnostics play a vital role in assessing breast cancer in patients.
  • Based on end use, the hospitals segment led the market with the largest revenue share of 37.82% in 2024. The usage of tissue diagnostic systems and services in hospitals & clinics has increased over the years.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology & Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional Scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. U.S. Tissue Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Emerging solutions pertaining to digital tissue diagnostics
      • 3.2.1.2. Advancements in imaging techniques and increasing affordability of diagnostics
      • 3.2.1.3. Growth of personalized therapeutics and diagnostics
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Presence of non-value-based reimbursement policy and high costs associated with usage of tissue diagnosis
  • 3.3. U.S. Tissue Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. U.S. Tissue Diagnostics Market: Technology & Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Tissue Diagnostics Market: Technology & Product Movement Analysis
  • 4.3. U.S. Tissue Diagnostics Market by Technology & Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Immunohistochemistry
    • 4.5.1. Immunohistochemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Instruments
      • 4.5.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.2.2. Slide Staining Systems
        • 4.5.2.2.1. Slide Staining Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.2.3. Tissue Microarrays
        • 4.5.2.3.1. Immunohistochemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.2.4. Tissue Processing Systems
        • 4.5.2.4.1. Tissue Processing Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.2.5. Slide Scanners
        • 4.5.2.5.1. Slide Scanners Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.2.6. Other Products
        • 4.5.2.6.1. Other Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Consumables
      • 4.5.3.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.3.2. Reagents
        • 4.5.3.2.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.3.3. Antibodies
        • 4.5.3.3.1. Antibodies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. In situ Hybridization
    • 4.6.1. In situ Hybridization Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Instruments
      • 4.6.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. Consumables
      • 4.6.3.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.4. Software
      • 4.6.4.1. Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Primary & Special Staining
    • 4.7.1. Primary & Special Staining Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.2. H&E Staining
      • 4.7.2.1. H&E Staining Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.3. Special Staining
      • 4.7.3.1. Special Staining Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Digital Pathology and Workflow
    • 4.8.1. Digital Pathology and Workflow Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.8.2. Whole Slide Imaging
      • 4.8.2.1. Whole Slide Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.8.3. Image Analysis Informatics
      • 4.8.3.1. Image Analysis Informatics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.8.4. Information Management System Storage & Communication
      • 4.8.4.1. Information Management System Storage & Communication Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Anatomic Pathology
    • 4.9.1. Anatomic Pathology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.9.2. Instruments
      • 4.9.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.9.2.2. Microtomes & Cryostat Microtomes
        • 4.9.2.2.1. Microtomes & Cryostat Microtomes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.9.2.3. Tissue Processors
        • 4.9.2.3.1. Tissue Processors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.9.2.4. Automatic Strainers
        • 4.9.2.4.1. Automatic Strainers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.9.2.5. Other Products
        • 4.9.2.5.1. Other Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.9.3. Consumables
      • 4.9.3.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.9.3.2. Reagents & Antibodies
        • 4.9.3.2.1. Reagents & Antibodies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.9.3.3. Probes & Kits
        • 4.9.3.3.1. Probes & Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.9.3.4. Others
        • 4.9.3.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Tissue Diagnostics Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Tissue Diagnostics Market: Application Movement Analysis
  • 5.3. U.S. Tissue Diagnostics Market by Application Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Breast Cancer
    • 5.5.1. Breast Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Non-Small Cell Lung Cancer
    • 5.6.1. Non-Small Cell Lung Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Prostate Cancer
    • 5.7.1. Prostate Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Gastric Cancer
    • 5.8.1. Gastric Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Other Cancers
    • 5.9.1. Other Cancers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Tissue Diagnostics Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Tissue Diagnostics Market: End Use Movement Analysis
  • 6.3. U.S. Tissue Diagnostics Market by End Use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Hospitals
    • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Research Laboratories
    • 6.6.1. Research Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Pharmaceutical Organizations
    • 6.7.1. Pharmaceutical Organizations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. CRO
    • 6.8.1. CRO Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Recent Developments & Impact Analysis by Key Market Participants
  • 7.3. Company Market Share Analysis, 2024
  • 7.4. Key Company Profiles
    • 7.4.1. Merck KGaA
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Thermo Fisher Scientific, Inc
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. F. Hoffmann-La Roche Ltd
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Abbott Laboratories
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Siemens Healthineers AG
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Danaher
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. bioMerieux SA
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. QIAGEN
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Becton, Dickinson & Company (BD)
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Agilent Technologies, Inc
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. General Electric Company
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. BioGenex
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiatives
    • 7.4.13. Cell Signaling Technology, Inc
      • 7.4.13.1. Company overview
      • 7.4.13.2. Financial performance
      • 7.4.13.3. Product benchmarking
      • 7.4.13.4. Strategic initiatives
    • 7.4.14. Bio SB
      • 7.4.14.1. Company overview
      • 7.4.14.2. Financial performance
      • 7.4.14.3. Product benchmarking
      • 7.4.14.4. Strategic initiatives
    • 7.4.15. DiaGenic ASA
      • 7.4.15.1. Company overview
      • 7.4.15.2. Financial performance
      • 7.4.15.3. Product benchmarking
      • 7.4.15.4. Strategic initiatives
    • 7.4.16. Sakura Finetek Japan Co., Ltd
      • 7.4.16.1. Company overview
      • 7.4.16.2. Financial performance
      • 7.4.16.3. Product benchmarking
      • 7.4.16.4. Strategic initiatives
    • 7.4.17. Abcam plc
      • 7.4.17.1. Company overview
      • 7.4.17.2. Financial performance
      • 7.4.17.3. Product benchmarking
      • 7.4.17.4. Strategic initiatives
    • 7.4.18. Enzo Life Sciences, Inc
      • 7.4.18.1. Company overview
      • 7.4.18.2. Financial performance
      • 7.4.18.3. Product benchmarking
      • 7.4.18.4. Strategic initiatives
    • 7.4.19. VITRO SA (Master Diagnostica)
      • 7.4.19.1. Company overview
      • 7.4.19.2. Financial performance
      • 7.4.19.3. Product benchmarking
      • 7.4.19.4. Strategic initiatives
    • 7.4.20. TissueGnostics GmbH
      • 7.4.20.1. Company overview
      • 7.4.20.2. Financial performance
      • 7.4.20.3. Product benchmarking
      • 7.4.20.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 U.S. Tissue Diagnostics market, by Technology & Product, 2018 - 2030 (USD Million)
  • Table 4 U.S. Tissue Diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 5 U.S. Tissue Diagnostics market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value chain-based sizing & forecasting
  • Fig. 5 Market formulation & validation
  • Fig. 6 U.S. tissue diagnostics market segmentation
  • Fig. 7 Market driver analysis (current & future impact)
  • Fig. 8 Market restraint analysis (current & future impact)
  • Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 10 Porter's five forces analysis
  • Fig. 11 U.S. tissue diagnostics market, technology & product outlook key takeaways 2024 & 2030 (USD Million)
  • Fig. 12 U.S. tissue diagnostics market, application outlook key takeaways 2024 & 2030 (USD Million)
  • Fig. 13 U.S. tissue diagnostics market, end use outlook key takeaways 2024 & 2030 (USD Million)
  • Fig. 14 Immunohistochemistry market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Instruments market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Slide Staining Systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Tissue Microarrays market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Tissue Processing Systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Slide Scanners market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Other Products market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Consumables market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Reagents market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Antibodies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Kits market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 In situ Hybridization market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Instruments market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Consumables market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Software market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Primary & Special Staining market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 H&E Staining market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Special Staining market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Digital Pathology and Workflow market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Whole Slide Imaging market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Image Analysis Informatics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Information Management System Storage & Communication market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Anatomic Pathology market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Instruments market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Microtomes &Cryostat Microtomes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Tissue Processors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Automatic Strainers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Other Products market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Consumables market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Reagents & Antibodies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Probes & Kits market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Breast Cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Non-Small Cell Lung Cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Prostate Cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Gastric Cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Other Cancers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Hospital market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Research Laboratories market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Pharmaceutical Organizations market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 CRO market revenue estimates and forecasts, 2018 - 2030 (USD Million)